🇺🇸 FDA

Intelligence Platform

Patents

Browse 793 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8609838

Pyrimidine substituted purine derivatives

VERASTEM, INC. · Granted Tue Dec 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8598322

Anti CEACAM1 antibodies and methods of using same

TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8597655

Recombinant fusion protein and polynucleotide construct for immunotoxin production

The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8592464

Nitric oxide furoxan derivative compounds endowed with antitumoral activity

HUMANITAS MIRASOLE S.P.A. · Granted Tue Nov 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8580231

Compositions and methods comprising magnetic resonance contrast agents

Northwestern University · Granted Tue Nov 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8580822

Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors

REVIVA PHARMACEUTICALS, INC. · Granted Tue Nov 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8575167

Spiro compounds having stearoyl-CoA desaturase action

Takeda Pharmaceutical Company Limited · Granted Tue Nov 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8569379

Use of rasagiline for the treatment of olfactory dysfunction

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8552147

Peptides and compositions for prevention of cell adhesion and methods of using same

TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Tue Oct 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8545813

Pre-templated macromolecular architectures with multiple Gd(III) complexes and methods of

Northwestern University · Granted Tue Oct 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8541457

Aminothiazole derivatives as human stearoyl-CoA desaturase inhibitors

Xenon Pharmaceuticals Inc. · Granted Tue Sep 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8541185

Method of predicting responsiveness to autologous adoptive cell transfer therapy

TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Tue Sep 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8541417

Poly (ADP-ribose) polymerase (PARP) inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Sep 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8541403

Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) for use in trea

BIOMARIN PHARMACEUTICAL INC. · Granted Tue Sep 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8535656

Amphiphilic polymer-protein conjugates and methods of use thereof

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Sep 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8529907

Methods of treating ophthalmic disorders

TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Tue Sep 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8512712

Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

ONCOLYTICS BIOTECH INC. · Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8512991

Beta 1,4-galactosyltransferases with altered donor and acceptor specificities, composition

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8507437

Apoptosis-modulating p53 protein therapy for vascular disorders and nanoparticles containi

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Aug 13 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8501692

Compositions and methods for altering cocaine esterase activity

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8491890

Methods and compositions for inhibiting diseases of the central nervous system

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Jul 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8486909

Compositions and methods for the diagnosis and treatment of inflammatory disorders and fib

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Jul 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8481551

Gyrase and topoisomerase IV inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Jul 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8481552

Solid forms of gyrase inhibitor (R)-1-ethyl-3-[5-[2-(1-hydroxy-1-methyl-ethyl)pyrimidin-5-

Vertex Pharmaceuticals Incorporated · Granted Tue Jul 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted